Catalyst Wire Dossier Catalyst Wire Dossier

Teropavimab

teropavimab
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Teropavimab, covering 2025-01-27 to 2025-07-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection [Phase 2]

See pricing